Skip to content
OpenCapital
Get started

BioAtla, Inc. BCAB Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

Revenue$2.0MBeat by $1.3M
EPS-$8.00Beat by $4.00
Revenue estimate$700.0K
EPS estimate-$12.00

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$8.50

Versus estimates

Revenue

Q4 2025$2.0MBeat by $1.3M
Q3 2024$11.0M

Diluted EPS

Q4 2025-$8.00Beat by $4.00
Q3 2025-$0.27Beat by $0.04Q2 2025-$0.31Miss by $0.02Q1 2025-$0.29Miss by $0.01Q4 2024-$0.32Beat by $0.08Q3 2024-$0.22Beat by $0.12

Ask the moment BioAtla, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioAtla, Inc. report Q4 2025 earnings?
BioAtla, Inc. (BCAB) reported Q4 2025 earnings on March 31, 2026 before market open.
What were BioAtla, Inc.'s Q4 2025 revenue and EPS?
BioAtla, Inc. reported revenue of $2.0M and eps of $-8.00 for Q4 2025.
Did BioAtla, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $700.0K by $1.3M. EPS beat the consensus estimate of $-12.00 by $4.00.
How did BioAtla, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2400.0% from $-0.32.
Where can I find BioAtla, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-134501) and the 10-K periodic report (0001193125-26-134499) directly on SEC EDGAR. The filing index links above go to sec.gov.